Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Delfau

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Neuroimmunology|January 5, 2002
Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndromeA Plonquet, R K Gherardi, A Créange, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2007
Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphomaA Plonquet, C Haioun, J-P Jais, et al.
The American Journal of Surgical Pathology|February 16, 1999
CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC)T Petrella, S Dalac, M Maynadié, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 21, 2014
Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literatureS Ingen-Housz-Oro, N Franck, N Beneton, et al.
The British Journal of Dermatology|July 8, 2015
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study GroupC Hurabielle, S Ingen-Housz-Oro, N Ortonne, et al.
Leukemia|December 16, 2006
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936M Brüggemann, H White, P Gaulard, et al.
Leukemia|August 25, 2012
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferationsA W Langerak, P J T A Groenen, M Brüggemann, et al.
Leukemia|December 16, 2006
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936P A S Evans, Ch Pott, P J T A Groenen, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Neuroimmunology|January 5, 2002
Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndromeA Plonquet, R K Gherardi, A Créange, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2007
Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphomaA Plonquet, C Haioun, J-P Jais, et al.
The American Journal of Surgical Pathology|February 16, 1999
CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC)T Petrella, S Dalac, M Maynadié, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 21, 2014
Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literatureS Ingen-Housz-Oro, N Franck, N Beneton, et al.
The British Journal of Dermatology|July 8, 2015
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study GroupC Hurabielle, S Ingen-Housz-Oro, N Ortonne, et al.
Leukemia|December 16, 2006
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936M Brüggemann, H White, P Gaulard, et al.
Leukemia|August 25, 2012
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferationsA W Langerak, P J T A Groenen, M Brüggemann, et al.
Leukemia|December 16, 2006
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936P A S Evans, Ch Pott, P J T A Groenen, et al.
Pageof 6